Citation Impact

Citing Papers

ggtree : an r package for visualization and annotation of phylogenetic trees with their covariates and other associated data
2016 Standout
Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting
2016 Science
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy
2010
Bone grafts and biomaterials substitutes for bone defect repair: A review
2017 Standout
Varicella vaccination in Europe – taking the practical approach
2009
A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1
2023 StandoutNobel
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
2012 Standout
The Incidence and Clinical Characteristics of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination
2009
Prevalence and Risk Factors for Infection With Herpes Simplex Virus Type-1 and -2 Among Lesbians
2003
Epstein‐barr virus antibody patterns preceding the diagnosis of non‐hodgkin's lymphoma
1991
SARS and MERS: recent insights into emerging coronaviruses
2016 Standout
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
2013
Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?
2014 Standout
Inhibition of HIV replication by Hyssop officinalis extracts
1990
Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)
2016
Development of vaccines and antivirals for combating viral pandemics
2020 StandoutNobel
An Innovative Topical Drug Formulation for Wound Healing and Infection Treatment: In vitro and in vivo Investigations of a Povidone-Iodine Liposome Hydrogel
2000
Seroprevalence of Herpes Simplex Virus Types 1 and 2--United States, 1999-2010
2013
An overview of tissue and whole organ decellularization processes
2011 Standout
Virus safety of a porcine‐derived medical device: Evaluation of a viral inactivation method
2002
A Strategy for O-Glycoproteomics of Enveloped Viruses—the O-Glycoproteome of Herpes Simplex Virus Type 1
2015
Deep sequencing: Becoming a critical tool in clinical virology
2014
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents
2020 Standout
Seasonal influenza: The burden of disease in children
2011
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Neonatal Herpes Disease following Maternal Antenatal Antiviral Suppressive Therapy: A Multicenter Case Series
2012
The use of sinecatechins (polyphenon E) ointment for treatment of external genital warts
2012
Antiherpes virus activity of extracts from the medicinal plant Geranium sanguineum L.
1998
The biochemistry and medical significance of the flavonoids
2002 Standout
Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response
2001
Influenza in pregnancy
2012
Impact of Immunosuppression on Recall Immune Responses to Influenza Vaccination in Stable Renal Transplant Recipients
2013
Graft-versus-host disease
2009 Standout
Herpesvirus-Associated Encephalitis: an Update
2022
Helicobacter pylori Infection and Gastric Lymphoma
1994 Standout
Herpes Viruses in Transplant Recipients: HSV, VZV, Human Herpes Viruses, and EBV
2010
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study
2010 Standout
Vaccines for Transplant Recipients
2001
Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance
2014
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Immune Efficacy of First and Repeat Trivalent Influenza Vaccine in Healthy Subjects and Hemodialysis Patients
2014
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Hygienic hand antiseptics: Should they not have activity and label claims against viruses?
2002
Update on Myocarditis
2012 Standout
Varicella zoster virus infection
2015
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
2005 Standout
Nosocomial influenza in children
2003
Anti-inflammatory properties of a liposomal hydrogel with povidone-iodine (Repithel®) for wound healing in vitro
2008
Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT
2005
Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Clinacanthus nutans (Burm. f.) Lindau: A comprehensive review
2017 Standout
Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care
2020 Standout
Quantification of growth factors in allogenic bone grafts extracted with three different methods
2006
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens
2018
DnaSP 6: DNA Sequence Polymorphism Analysis of Large Data Sets
2017 Standout
Age‐Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global Review
2002
Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA)
2015
Herpes Zoster
2013 Standout
Decellularization of tissues and organs
2006 Standout
Human 4F5 single-chain Fv antibody recognizing a conserved HA1 epitope has broad neutralizing potency against H5N1 influenza A viruses of different clades
2013
Parvovirus B19 Infection in Pregnancy
2014
Zoster Vaccine: Current Status and Future Prospects
2010
The Association of Epstein-Barr Virus (Ebv) with T Cell Lymphoproliferations and hodgkin's Disease: Two New Developments in the Ebv Field
1993
Multiple sclerosis
2002 Standout
Epstein–Barr Virus Infection
2000 Standout
Systematic review of incidence and complications of herpes zoster: towards a global perspective
2014 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes
2016
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
2020 StandoutNobel
Evolution of the immune system in humans from infancy to old age
2015 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells
2017
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection
2008
Viral Encephalitis in England, 1989–1998: What Did We Miss?
2003
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Functional Hydrogels as Wound Dressing to Enhance Wound Healing
2021 Standout
Plant Products as Antimicrobial Agents
1999 Standout
Approved Antiviral Drugs over the Past 50 Years
2016
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
2020 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Expansion of Genotypic Diversity and Establishment of 2009 H1N1 Pandemic-Origin Internal Genes in Pigs in China
2014
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Phytochemicals: nutraceuticals and human health
2000 Standout
Efficacy of Hospital Germicides against Adenovirus 8, a Common Cause of Epidemic Keratoconjunctivitis in Health Care Facilities
2006
Evaluation of Confirmatory Strategies for Detection of Type-Specific Antibodies against Herpes Simplex Virus Type 2
2002
Fear and Practice Modifications among Dentists to Combat Novel Coronavirus Disease (COVID-19) Outbreak
2020 Standout
Chemical Glycoproteomics
2016 StandoutNobel
Neonatal Herpes Simplex Infection
2004

Works of Andreas Sauerbrei being referenced

Sensitivity of human adenoviruses to different groups of chemical biocides
2004
Prevalence of influenza A and B antibodies in pregnant women and their offspring
2009
Seroprevalence of parvovirus B19 in the German population
2008
Laboratory diagnosis of herpes zoster
1999
The Congenital Varicella Syndrome
2000
Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany
2013
Evolution and world-wide distribution of varicella–zoster virus clades
2010
Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations?relevance for the incidence of genital herpes
2000
Comparative Testing of Liposomal and Aqueous Formulations of Povidone-Iodine for Their Angioirritative Potential at the Chorioallantoic Membrane of ex ovo Cultivated Chick Embryos
2003
Leitlinie der Deutschen Vereinigung zur Bekämpfung der Viruskrankheiten (DVV) e. V. und des Robert Koch-Instituts (RKI) zur Prüfung von chemischen Desinfektionsmitteln auf Wirksamkeit gegen Viren in der Humanmedizin
2015
Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients
2012
Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany
2017
Neonatal Varicella
2001
Die Labordiagnose des Herpes zoster: Virologie oder Serologie?
2002
Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections
2006
Virucidal efficacy of povidone-iodine-containing disinfectants
2010
Mitteilung der Deutschen Vereinigung zur Bekämpfung der Viruskrankheiten e. V. (DVV) und des Robert Koch-Instituts (RKI) zur Veröffentlichung der aktualisierten Fassung der Leitlinie zur Prüfung von chemischen Desinfektionsmitteln auf Wirksamkeit gegen Viren in der Humanmedizin (Suspensionstest) – Fassung vom 1. Dezember 2014
2015
Virucidal efficacy of a combination of 0.2% peracetic acid and 80% (v/v) ethanol (PAA-ethanol) as a potential hand disinfectant
2000
Varicella vaccination in children after bone marrow transplantation
1997
Seroprevalence of influenza A and B in German infants and adolescents
2009
Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child
2002
Therapeutic effect of (E)‐5‐(2‐bromovinyl)‐2′‐deoxyuridine, caffeic acid oxidation product, and trisodiumphosphonoformate on cutaneous herpes simplex virus type 1 infection in guinea pigs
1987
Testing of herpes simplex virus for resistance to antiviral drugs
2010
Virological diagnosis of herpes simplex encephalitis
2000
Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 1: Herpes simplex virus infections
2006
Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes
2014
Acyclovir resistance in herpes simplex encephalitis
2010
Resistance testing of clinical varicella-zoster virus strains
2011
Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors
2005
Different genotype pattern of varicella‐zoster virus obtained from patients with varicella and zoster in Germany
2007
Reassortants of the pandemic (H1N1) 2009 virus and establishment of a novel porcine H1N2 influenza virus, lineage in Germany
2013
Virucidal and Chlamydicidal Activities of Eye Drops with Povidone-Iodine Liposome Complex
2000
Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine
2002
Varicella-Zoster Virus Infections During Pregnancy: Epidemiology, Clinical Symptoms, Diagnosis, Prevention and Therapy
2005
Genetic Profile of an Oka Varicella Vaccine Virus Variant Isolated from an Infant with Zoster
2004
Demonstration of Epstein-Barr Virus in Malignant Non-Hodgkin’s Lymphomas
1986
Anti-BK Virus Activity of Nucleoside Analogs
2008
Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006
2011
Prevalence of antibodies against influenza A and B viruses in children in Germany, 2008 to 2010
2014
Sequencing of 21 Varicella-Zoster Virus Genomes Reveals Two Novel Genotypes and Evidence of Recombination
2011
Rankless by CCL
2026